Diagnostics company bioMerieux (PARIS:BIM) has received 510(k) clearance from the U.S. Food and Drug Administration for a test to detect and screen for methicillin-resistant staphylococcus, more ...

An infectious disease test developer has raised $1.9 million in a series B financing round to advance its MRSA screening panel. It will also use the funds to develop its new molecular diagnostic ...

Polymerase chain reaction testing may be more clinically effective than chromogenic agar for MRSA screening, according to research published in BMC Infectious Diseases. For their study, researcher ...

MORRIS, ILLINOIS, USA, April 3, 2023/EINPresswire.com/ -- “MRSA and Staph aureus infections are the number one problem in U.S. healthcare facilities and greatly ...

July 3, 2010 — A test to detect methicillin-resistant Staphylococcus aureus (MRSA) and S aureus (SA) has been recalled by the manufacturer based on an increasing number of complaints about false ...

On Monday, the U.S. Food and Drug Administration approved a new test for methicillin-resistant Staphylococcus aureus detection manufactured by Cepheid. Cepheid’s Xpert MRSA NxG test delivers ...

Co announces it received clearance from the FDA to market its Xpert M.R.S.A test, which runs on the GeneXpert System, for the rapid detection of Methicillin-resistant Staphylococcus aureus. "Currently ...

Scientists have identified a new strain of MRSA that occurs both in human and dairy cow populations and could go undetected under standard MRSA testing, according to a University of Cambridge news ...

Researchers have concluded MRSA screening using polymerase chain reaction generally demonstrated lower turnaround time and number of isolation days than chromogenic agar, according to research ...